Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose alfentanil pretreatment to reduce sufentanil-induced cough during general anesthesia induction
ChiCTR2300069286Phase 4Recruiting
- Sponsor
- Lishui People's Hospital
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of alfentanil in None (2 arms), sponsored by Lishui People's Hospital. Primary endpoint: Incidence and severity of cough. Started Mar 2023; status: recruiting.
02
Drugs
alfentanil
Beyond the preview
Go deeper on ChiCTR2300069286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300069286.